Lantern Pharma Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. CME
8. HUMA
9. NVDA
10. INTC

Go back to Lantern Pharma Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Operational Highlights
(NASDAQ: LTRN) Delayed: 4.07 +0.19 (4.90%)
Previous Close $3.88    52 Week High $ 
Open $3.92    52 Week Low $ 
Day High $4.12    P/E N/A 
Day Low $3.82    EPS $ 
Volume 155,927